Cargando…
Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination
Background: Neurofibromatosis type 1 (NF1) has no current effective treatments beyond surgery. Topical photodynamic therapy (PDT) has the potential to provide a less invasive treatment modality. Objective: Based on murine data, we hypothesized PDT could be used for the treatment of cutaneous neurofi...
Autores principales: | Quirk, Brendan, Olasz, Edit, Kumar, Suresh, Basel, Donald, Whelan, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219184/ https://www.ncbi.nlm.nih.gov/pubmed/33470897 http://dx.doi.org/10.1089/photob.2020.4957 |
Ejemplares similares
-
An Accurate Value for the Absorption Coefficient of Silicon at 633 nm
por: Geist, Jon, et al.
Publicado: (1990) -
Therapeutic effects of topical 5-aminolevulinic acid photodynamic therapy
por: Hu, Yin-E, et al.
Publicado: (2016) -
A GPS-Referenced Wavelength Standard for High-Precision Displacement Interferometry at λ = 633 nm
por: Blumröder, Ulrike, et al.
Publicado: (2023) -
Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis
por: Bartosińska, Joanna, et al.
Publicado: (2022) -
Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up
por: Ko, Dong-Yeob, et al.
Publicado: (2014)